Steven D. Schwartz, MD
(310) 206-7474 (Office)
100 Stein Plaza
Los Angeles, CA 90095 , US map
Dr. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity (ROP), and diabetic eye disease. Additionally, his focus includes development and evaluation of novel medical device technologies, imaging technologies, surgical equipment (including surgical robots), and drug delivery systems, with particular emphasis on diagnostic and treatment applications. Dr. Schwartz’ clinical research focuses on trials of novel pharmacotherapeutic agents to discover treatments for both wet and dry age-related macular degeneration, ROP, and diabetic retinopathy.
Through innovative teleophthalmological approaches to screen for eye diseases (such as diabetic retinopathy and ROP), Dr. Schwartz is dedicated to improving both the quality of and access to specialized ophthalmology care.
This year, Dr. Schwartz led two new clinical trials testing the use of stem cell-derived retinal pigment epithelial cells to address vision loss in people suffering from Stargardt's macular dystrophy and dry age-related macular degeneration.
- Ahmanson Professor of Ophthalmology
- Chief, Retina Division
- Jules Stein Eye Institute
- Professor of Ophthalmology
- David Geffen School of Medicine at UCLA